191 related articles for article (PubMed ID: 34074603)
21. Gestational trophoblastic disease- rare, sometimes dramatic, and what we know so far.
Strickland AL; Gwin K
Semin Diagn Pathol; 2022 May; 39(3):228-237. PubMed ID: 35400536
[TBL] [Abstract][Full Text] [Related]
22. Histopathological diagnosis of hydatidiform mole: contemporary features and clinical implications.
Sebire NJ
Fetal Pediatr Pathol; 2010; 29(1):1-16. PubMed ID: 20055560
[TBL] [Abstract][Full Text] [Related]
23. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms.
Xu D; Feng F; Pei Y; Zhang Y; Wu Y; Guo Y; Cui W
Am J Reprod Immunol; 2020 May; 83(5):e13233. PubMed ID: 32187420
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
Lösch A; Kainz C
Acta Obstet Gynecol Scand; 1996 Sep; 75(8):753-6. PubMed ID: 8906012
[TBL] [Abstract][Full Text] [Related]
26. Measurement of Human Chorionic Gonadotrophin in Women with Gestational Trophoblastic Disease.
McMahon LM; Joyce CM; Cuthill L; Mitchell H; Jabbar I; Sweep F;
Gynecol Obstet Invest; 2024; 89(3):178-197. PubMed ID: 37307803
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 2 Human Chorionic Gonadotropin Immunoassays Commercially Available for Monitoring Patients With Gestational Trophoblastic Disease.
de Souza JMQ; Braga A; Sanches Dos Santos R; Ramos MM; Cortés-Charry R; Maestá I
Int J Gynecol Cancer; 2017 Sep; 27(7):1494-1500. PubMed ID: 28692637
[TBL] [Abstract][Full Text] [Related]
28. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
Kanda K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
[TBL] [Abstract][Full Text] [Related]
29. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
30. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
31. Cytological distribution of chorionic gonadotropin subunit and placental lactogen messenger RNA in neoplasms derived from human placenta.
Hoshina M; Hussa R; Pattillo R; Boime I
J Cell Biol; 1983 Oct; 97(4):1200-6. PubMed ID: 6619191
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of gestational trophoblastic disease: 2021 update.
Ngan HYS; Seckl MJ; Berkowitz RS; Xiang Y; Golfier F; Sekharan PK; Lurain JR; Massuger L
Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):86-93. PubMed ID: 34669197
[TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor.
Kurman RJ; Young RH; Norris HJ; Main CS; Lawrence WD; Scully RE
Int J Gynecol Pathol; 1984; 3(1):101-21. PubMed ID: 6329973
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
35. [Trophoblastic diseases].
ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
[TBL] [Abstract][Full Text] [Related]
36. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
37. Gestational trophoblastic disease: experience at Nawabshah Hospital.
Nizam K; Haider G; Memon N; Haider A
J Ayub Med Coll Abbottabad; 2009; 21(1):94-7. PubMed ID: 20364752
[TBL] [Abstract][Full Text] [Related]
38. Recognising gestational trophoblastic disease.
Alhamdan D; Bignardi T; Condous G
Best Pract Res Clin Obstet Gynaecol; 2009 Aug; 23(4):565-73. PubMed ID: 19375983
[TBL] [Abstract][Full Text] [Related]
39. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
40. Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report.
Sasaki S; Sasaki Y; Iino K
J Reprod Med; 2010; 55(7-8):317-20. PubMed ID: 20795345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
